Gestational diabetes mellitus
Open accessThe DOI matches its Crossref record; 81 of the 81 references it cites were found in a registry or an index.
Abstract
Gestational diabetes mellitus (GDM) is defined as glucose intolerance of various degrees that is first detected during pregnancy. GDM is detected through the screening of pregnant women for clinical risk factors and, among at-risk women, testing for abnormal glucose tolerance that is usually, but not invariably, mild and asymptomatic. GDM appears to result from the same broad spectrum of physiological and genetic abnormalities that characterize diabetes outside of pregnancy. Indeed, women with GDM are at high risk for having or developing diabetes when they are not pregnant. Thus, GDM provides a unique opportunity to study the early pathogenesis of diabetes and to develop interventions to prevent the disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Most hospitalized persons require 25 to 35 calories/kg/day; critically ill persons require between 15 and 25 calories/kg/day.1400–1405”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [1403]
In the citing paper
“In most cases, this hyperglycemia is the result of impaired glucose tolerance due to pancreatic β-cell dysfunction on a background of chronic insulin resistance.”
From The Pathophysiology of Gestational Diabetes Mellitus (2018) · cites this paper as [22]
In the citing paper
“The risk factors for progression to type 2 diabetes include maternal age, prepartum and postpartum BMI, family history of type 2 diabetes, receipt of insulin for gestational diabetes, and fasting glucose level during pregnancy.6,[24][25][26]”
From Association of Gestational Diabetes With Maternal Disorders of Glucose Metabolism and Childhood Adiposity (2018) · cites this paper as [25]
In the citing paper
“There is a progressive increase in insulin resistance, predominantly due to increased circulating placental hormones, including growth hormone, corticotrophin-releasing hormone, human placental lactogen, prolactin, estrogen, and progesterone.”
From Maternal Overnutrition and Fetal Programming: Long-Term Metabolic, Cognitive, and Epigenetic Consequences (2026) · cites this paper as [37]
In the citing paper
“Evidence from late-gestation studies demonstrates that insulin sensitivity is reduced by 40–80% in gravidae with normal or elevated body mass index.”
From Maternal Overnutrition and Fetal Programming: Long-Term Metabolic, Cognitive, and Epigenetic Consequences (2026) · cites this paper as [37]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus* (2002) · Diabetes Care · doi:10.2337/diacare.25.2007.s5 · Cited by 10,338
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (2003) · Diabetes Care · doi:10.2337/diacare.26.2007.s5 · Cited by 2,689
Gestational Diabetes and the Incidence of Type 2 Diabetes
Kim, C., Newton, K. M., & Knopp, R. H. (2002) · Diabetes Care · doi:10.2337/diacare.25.10.1862 · Cited by 2,276
Diagnosis and Classification of Diabetes Mellitus
American Diabetes Association (2004) · Diabetes Care · doi:10.2337/diacare.27.2007.s5 · Cited by 1,666
Buchanan, T. A., Xiang, A. H., Peters, R. K., Kjos, S. L., Marroquin, A., Goico, J., Ochoa, C., Tan, S., Berkowitz, K., Hodis, H. N., et al. (2002) · Diabetes · doi:10.2337/diabetes.51.9.2796 · Cited by 1,339
Self-citation(1964) · PubMed · Cited by 1,230
Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young
Fajans, S. S., Bell, G. I., & Polonsky, K. S. (2001) · New England Journal of Medicine · doi:10.1056/nejmra002168 · Cited by 1,123 · cited 8×
“These include mutations in genes coding for: (a) glucokinase (MODY 2) (29, 33–35); (b) hepatocyte nuclear factor 1α (MODY 3) (29); (c) and insulin promoter factor 1 (MODY 4) (29).”
BackgroundInfluentialA comparison of glyburide and insulin in women with gestational diabetes mellitus
Langer, O., Conway, D. L., Berkus, M. D., Xenakis, E. M.-J., & Gonzales, O. (2000) · New England Journal of Medicine · doi:10.1056/nejm200010193431601 · Cited by 924
Epidemiology of gestational diabetes mellitus and its association with Type 2 diabetes
Ben‐Haroush, A., Yogev, Y., & Hod, M. (2004) · Diabetic Medicine · doi:10.1046/j.1464-5491.2003.00985.x · Cited by 856
Longitudinal changes in insulin release and insulin resistance in nonobese pregnant women
Catalano, P. M., Tyzbir, E. D., Roman, N. M., Amini, S. B., & Sims, E. A. H. (1991) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(91)90012-g · Cited by 709
Catalano, P. M., Huston, L., Amini, S. B., & Kalhan, S. C. (1999) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(99)70662-9 · Cited by 680 · cited 2×
“Sequential measurements of insulin sensitivity performed in the same women before pregnancy, early in the second trimester, and in the third trimester have documented insulin resistance in both lean and obese women who go on to develop GDM (18, 24).”
Background(1986) · Annals of Internal Medicine · doi:10.7326/0003-4819-105-3-461 · Cited by 663
Carbohydrate metabolism during pregnancy in control subjects and women with gestational diabetes
Catalano, P. M., Tyzbir, E. D., Wolfe, R. R., Calles, J., Roman, N. M., Amini, S. B., & Sims, E. A. (1993) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1993.264.1.e60 · Cited by 484 · cited 1×
“Sequential measurements of insulin sensitivity performed in the same women before pregnancy, early in the second trimester, and in the third trimester have documented insulin resistance in both lean and obese women who go on to develop GDM (18, 24).”
BackgroundKjos, S. L., & Buchanan, T. A. (1999) · New England Journal of Medicine · doi:10.1056/nejm199912023412307 · Cited by 459
Self-citationBuchanan, T. A., Metzger, B. E., Freinkel, N., & Bergman, R. N. (1990) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(90)91306-w · Cited by 426
Self-citation(1998) · PubMed · Cited by 404
Schmidt, M. I., Duncan, B. B., Reichelt, A. J., Branchtein, L., Matos, M. C., Costa e Forti, A., Spichler, E. R., Pousada, J. M. D. C., Teixeira, M. M., Yamashita, T., et al. (2001) · Diabetes Care · doi:10.2337/diacare.24.7.1151 · Cited by 390
Naylor, C. D. (1996) · JAMA · doi:10.1001/jama.1996.03530390031030 · Cited by 343 · cited 1×
“Table 3 was applied to a group of Caucasian women in Toronto, approximately 7% had GDM (6).”
MethodBuchanan, T. A. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.3.989 · Cited by 335 · cited 1×
“However, when insulin levels and responses are expressed relative to each individual’s degree of insulin resistance, a large defect in pancreatic β cell function is a consistent finding in women with prior GDM (23, 25, 27).”
BackgroundSelf-citationPeters, R. K., Xiang, A., Kjos, S. L., & Buchanan, T. A. (1996) · The Lancet · doi:10.1016/s0140-6736(96)90405-5 · Cited by 273
Self-citationFriedman, J. E., Ishizuka, T., Shao, J., Huston, L., Highman, T., & Catalano, P. (1999) · Diabetes · doi:10.2337/diabetes.48.9.1807 · Cited by 255 · cited 1×
“Alterations in the insulin signaling pathway (49–52), abnormal subcellular localization of GLUT4 transporters (53), reduced expression of PPARγ (49), increased expression of the membrane glycoprotein PC-1 (51), and reduced insulin-mediated glucose transport (52, 53) have been found in skeletal muscle or fat cells”
BackgroundC-Reactive Protein and Gestational Diabetes: The Central Role of Maternal Obesity
Retnakaran, R., Hanley, A. J. G., Raif, N., Connelly, P. W., Sermer, M., & Zinman, B. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030186 · Cited by 243 · cited 1×
“of leptin (41) and the inflammatory markers TNF-α (42) and C-reactive protein (43) and decreased levels of adiponectin (44, 45) in women with GDM.”
BackgroundEpidemiology of glucose intolerance and gestational diabetes in women of childbearing age.
King, H. (1998) · PubMed · Cited by 240
(1998) · PubMed · Cited by 239
Oral hypoglycaemic agents in 118 diabetic pregnancies
Hellmuth, E., Damm, P., & Mølsted‐Pedersen, L. (2000) · Diabetic Medicine · doi:10.1046/j.1464-5491.2000.00314.x · Cited by 228
Williams, M. A., Qiu, C., Muy-Rivera, M., Vadachkoria, S., Song, T., & Luthy, D. A. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031201 · Cited by 220
Catalano, P. M., Nizielski, S. E., Shao, J., Preston, L., Qiao, L., & Friedman, J. E. (2002) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00124.2001 · Cited by 220 · cited 3×
“Alterations in the insulin signaling pathway (49–52), abnormal subcellular localization of GLUT4 transporters (53), reduced expression of PPARγ (49), increased expression of the membrane glycoprotein PC-1 (51), and reduced insulin-mediated glucose transport (52, 53) have been found in skeletal muscle or fat cells”
BackgroundMultiple metabolic defects during late pregnancy in women at high risk for type 2 diabetes.
Xiang, A. H., Peters, R. K., Trigo, E., Kjos, S. L., Lee, W. P., & Buchanan, T. A. (1999) · Diabetes · doi:10.2337/diabetes.48.4.848 · Cited by 217 · cited 1×
“ity to stimulate glucose utilization (17, 18) and to suppress both glucose production (17, 18) and fatty acid levels (17).”
BackgroundSelf-citationInsulin Secretion during and after Pregnancy in Patients with Gestational Diabetes Mellitus1
Homko, C., Sivan, E., Chen, X., Reece, E. A., & Boden, G. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.2.7137 · Cited by 217 · cited 1×
“Values were measured at the end of 3-hour hyperglycemic clamps (plasma glucose, about 180 mg/dl) (22).”
MethodKautzky-Willer, A., Prager, R., Waldhäusl, W., Pacini, G., Thomaseth, K., Wagner, O. F., Ulm, M., Streli, C., & Ludvik, B. (1997) · Diabetes Care · doi:10.2337/diacare.20.11.1717 · Cited by 210 · cited 1×
“However, when insulin levels and responses are expressed relative to each individual’s degree of insulin resistance, a large defect in pancreatic β cell function is a consistent finding in women with prior GDM (23, 25, 27).”
BackgroundEllard, S., Beards, F., Allen, L. I. S., Shepherd, M., Ballantyne, E., Harvey, R., & Hattersley, A. T. (2000) · Diabetologia · doi:10.1007/s001250050038 · Cited by 209 · cited 1×
“(34) have provided 4 clinical criteria that have relatively high specificity for identifying women with the glucokinase mutations that cause 1 form of MODY, MODY2: (a)”
BackgroundTowner, D., Kjos, S. L., Leung, B., Montoro, M. M., Xiang, A., Mestman, J. H., & Buchanan, T. A. (1995) · Diabetes Care · doi:10.2337/diacare.18.11.1446 · Cited by 207
Self-citationIncreased plasma leptin in gestational diabetes
Kautzky-Willer, A., Pacini, G., Tura, A., Bieglmayer, C., Schneider, B., Ludvik, B., Prager, R., & Waldhäusl, W. (2001) · Diabetologia · doi:10.1007/s001250051595 · Cited by 194 · cited 1×
“of leptin (41) and the inflammatory markers TNF-α (42) and C-reactive protein (43) and decreased levels of adiponectin (44, 45) in women with GDM.”
BackgroundBuchanan, T. A., Kjos, S. L., Montoro, M. N., Wu, P. Y. K., Madrilejo, N. G., Gonzalez, M., Nunez, V., Pantoja, P. M., & Xiang, A. (1994) · Diabetes Care · doi:10.2337/diacare.17.4.275 · Cited by 186 · cited 1×
“onstrates signs of excessive adiposity — pregnancies in which the need to aggressively lower maternal glucose is the greatest (66, 67).”
BackgroundSelf-citationKjos, S. L., Schaefer-Graf, U., Sardesi, S., Peters, R. K., Buley, A., Xiang, A. H., Bryne, J. D., Sutherland, C., Montoro, M. N., & Buchanan, T. A. (2001) · Diabetes Care · doi:10.2337/diacare.24.11.1904 · Cited by 180 · cited 1×
“onstrates signs of excessive adiposity — pregnancies in which the need to aggressively lower maternal glucose is the greatest (66, 67).”
BackgroundSelf-citationKjos, S. L., Buchanan, T. A., Greenspoon, J. S., Montoro, M., Bernstein, G. S., & Mestman, J. H. (1990) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(11)90676-0 · Cited by 171
Self-citationDefects in Insulin Secretion and Action in Women With a History of Gestational Diabetes
Ryan, E. A., Imes, S. I., Liu, D., McManus, R., Finegood, D. T., Polonsky, K. S., & Sturis, J. (1995) · Diabetes · doi:10.2337/diab.44.5.506 · Cited by 171
Effects of maternal gestational diabetes on offspring adiposity at 4-7 years of age
Vohr, B. R., McGarvey, S. T., & Tucker, R. (1999) · Diabetes Care · doi:10.2337/diacare.22.8.1284 · Cited by 166
Liver‐Fat Accumulation and Insulin Resistance in Obese Women with Previous Gestational Diabetes
Tiikkainen, M., Tamminen, M., Häkkinen, A., Bergholm, R., Vehkavaara, S., Halavaara, J., Teramo, K., Rissanen, A., & Yki‐Järvinen, H. (2002) · Obesity Research · doi:10.1038/oby.2002.118 · Cited by 162 · cited 1×
“Increased content of fat in liver (46) and muscle (47) has”
BackgroundReduced Adiponectin Concentration in Women With Gestational Diabetes
Retnakaran, R., Hanley, A. J. G., Raif, N., Connelly, P. W., Sermer, M., & Zinman, B. (2004) · Diabetes Care · doi:10.2337/diacare.27.3.799 · Cited by 160 · cited 1×
“of leptin (41) and the inflammatory markers TNF-α (42) and C-reactive protein (43) and decreased levels of adiponectin (44, 45) in women with GDM.”
BackgroundInfluence of diagnostic criteria on the incidence of gestational diabetes and perinatal morbidity.
Magee, M. S., Walden, C. E., Benedetti, T. J., & Knopp, R. H. (1993) · PubMed · Cited by 160
Ward, W. K., Johnston, C. L. W., Beard, J. C., Benedetti, T. J., Halter, J. B., & Porte, D. (1985) · Diabetes · doi:10.2337/diab.34.9.861 · Cited by 159
Insulin Secretion during and after Pregnancy in Patients with Gestational Diabetes Mellitus
Cj, H. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.2.568 · Cited by 156
Kautzky-Willer, A., Krssak, M., Winzer, C., Pacini, G., Tura, A., Farhan, S., Wagner, O., Brabant, G., Horn, R., Stingl, H., et al. (2003) · Diabetes · doi:10.2337/diabetes.52.2.244 · Cited by 150 · cited 1×
“Increased content of fat in liver (46) and muscle (47) has”
BackgroundGarvey, W. T., Maianu, L., Zhu, J.-H., Hancock, J. A., & Golichowski, A. M. (1993) · Diabetes · doi:10.2337/diab.42.12.1773 · Cited by 142
Tumor necrosis factor system in insulin resistance in gestational diabetes
Winkler, G., Cseh, K., Baranyi, É., Melczer, Z., Speer, G., Hajós, P., Salamon, F., Turi, Z., Kovács, M., Vargha, P., et al. (2002) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(01)00355-2 · Cited by 140 · cited 2×
“of leptin (41) and the inflammatory markers TNF-α (42) and C-reactive protein (43) and decreased levels of adiponectin (44, 45) in women with GDM.”
BackgroundGumbiner, B., Low, C. C., & Reaven, P. D. (1998) · Diabetes Care · doi:10.2337/diacare.21.1.9 · Cited by 127
Buchanan, T. A., Xiang, A. H., Peters, R. K., Kjos, S. L., Berkowitz, K., Marroquin, A., Goico, J., Ochoa, C., & Azen, S. P. (2000) · Diabetes · doi:10.2337/diabetes.49.5.782 · Cited by 111
Self-citationShao, J., Catalano, P. M., Yamashita, H., Ruyter, I., Smith, S., Youngren, J., & Friedman, J. E. (2000) · Diabetes · doi:10.2337/diabetes.49.4.603 · Cited by 108 · cited 2×
“Alterations in the insulin signaling pathway (49–52), abnormal subcellular localization of GLUT4 transporters (53), reduced expression of PPARγ (49), increased expression of the membrane glycoprotein PC-1 (51), and reduced insulin-mediated glucose transport (52, 53) have been found in skeletal muscle or fat cells”
BackgroundThe effect of diabetic and prediabetic pregnancies on the fetus and newborn infant
Miller, H. C. (1946) · The Journal of Pediatrics · doi:10.1016/s0022-3476(46)80164-1 · Cited by 106 · cited 1×
“As early as in the 1940s, it was recognized that women who developed diabetes years after pregnancy had experienced abnormally high fetal and neonatal mortality (2).”
BackgroundInfluence of diagnostic criteria on the incidence of gestational diabetes and perinatal morbidity
Magee, M. S. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1993.03500050087031 · Cited by 99
Weng, J., Ekelund, M., Lehto, M., Li, H., Ekberg, G., Frid, A., Åberg, A., Groop, L. C., & Berntorp, K. (2002) · Diabetes Care · doi:10.2337/diacare.25.1.68 · Cited by 98 · cited 1×
“These include mutations in genes coding for: (a) glucokinase (MODY 2) (29, 33–35); (b) hepatocyte nuclear factor 1α (MODY 3) (29); (c) and insulin promoter factor 1 (MODY 4) (29).”
BackgroundSubclinical abnormalities of glucose metabolism in subjects with previous gestational diabetes
Catalano, P. M., Bernstein, I. M., Wolfe, R. R., Srikanta, S., Tyzbir, E. D., & Sims, E. A. H. (1986) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(86)90155-9 · Cited by 89
Evaluation of the Prediabetic State During Pregnancy
CARRINGTON, E. R., SHUMAN, C. R., & REARDON, H. S. (1957) · Obstetrics & Gynecology · doi:10.1097/00006250-195706000-00008 · Cited by 86 · cited 1×
“thought to be a transient condition that affected fetal outcomes adversely, then abated after delivery (3).”
BackgroundRissanen, J., Markkanen, A., Kärkkäinen, P., Pihlajamäki, J., Kekäläinen, P., Mykkänen, L., Kuusisto, J., Karhapää, P., Niskanen, L., & Laakso, M. (2000) · Diabetes Care · doi:10.2337/diacare.23.1.70 · Cited by 84 · cited 1×
“control and GDM subjects were found in genes coding for: (a) the islet-specific promoter of glucokinase (54), known to be important for glucose sensing by β cells; (b) calpain-10 (55), a gene associated with type 2 diabetes in Hispanic Americans and some other ethnic groups; (c) the sulfonylurea receptor 1 (56), which…”
BackgroundIncidence and Significance of Islet Cell Antibodies in Women With Previous Gestational Diabetes
Catalano, P. M., Tyzbir, E. D., & Sims, E. A. H. (1990) · Diabetes Care · doi:10.2337/diacare.13.5.478 · Cited by 71
Weijers, R. N. M., Bekedam, D. J., & Smulders, Y. M. (2002) · Diabetes Care · doi:10.2337/diacare.25.1.72 · Cited by 69
Petersen, J. S., Dyrberg, T., Damm, P., Kuhl, C. K., Mølsted‐Pedersen, L., & Buschard, K. (1996) · Diabetologia · doi:10.1007/s001250050578 · Cited by 69
Shao, J., Yamashita, H., Qiao, L., Draznin, B., & Friedman, J. E. (2002) · Diabetes · doi:10.2337/diabetes.51.1.19 · Cited by 69
Naylor, C. D. (1996) · JAMA · doi:10.1001/jama.275.15.1165 · Cited by 67
Saker, P. J., Hattersley, A. T., Barrow, B. A., Hammersley, M. S., McLellan, J.-A., Lo, Y. M. D., Olds, R. J., Gillmer, M. D. G., Holman, R. R., & Turner, R. C. (1996) · Diabetologia · doi:10.1007/s001250050577 · Cited by 64
Mitochondrial gene mutations in gestational diabetes mellitus
Chen, Y., Liao, W. X., Roy, A. C., Loganath, A., & Ng, S. C. (2000) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(99)00138-2 · Cited by 62
Yen, S. S. C., TSAI, C. C., & Vela, P. (1971) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(71)90490-x · Cited by 55
WARD, K. W., JOHNSON, C. L. W., BEARD, J. C., BENEDETTI, T. J., & PORTE, D. (1985) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-61-6-1039 · Cited by 55
Ward, W. K., Johnston, C., Beard, J. C., et al. (1985) · Diabetes · doi:10.2337/diabetes.34.9.861 · Cited by 55
Buchanan, T. A., Metzger, B., Freinkel, N., & Bergman, R. N. (1991) · International Journal of Gynecology & Obstetrics · doi:10.1016/0020-7292(91)90237-y · Cited by 54
Self-citationXiang, A. H., Peters, R. K., Kjos, S. L., Goico, J., Ochoa, C., Marroquin, A., Tan, S., Hodis, H. N., Azen, S. P., & Buchanan, T. A. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-032044 · Cited by 51 · cited 1×
“Stabilization of β cell function was also observed when troglitazone treatment was started at the time of initial detection of diabetes by annual glucose tolerance testing (71).”
BackgroundSelf-citationGunton, J. E., Hitchman, R., & McElduff, A. (2001) · Australian and New Zealand Journal of Obstetrics and Gynaecology · doi:10.1111/j.1479-828x.2001.tb01205.x · Cited by 48
Defects in insulin secretion and action in women with a history of gestational diabetes
Ryan, E. A., Imes, S., Liu, D., et al. (1995) · Diabetes · doi:10.2337/diabetes.44.5.506 · Cited by 47
Metformin and gestational diabetes
Glueck, C. J., Goldenberg, N., Streicher, P., & Wang, P. (2003) · Current Diabetes Reports · doi:10.1007/s11892-003-0022-0 · Cited by 43
Fast and cAMP-Sensitive Mode of Ca2+-Dependent Exocytosis in Pancreatic β-Cells
Kasai, H., Suzuki, T., Liu, T.-T., Kishimoto, T., & Takahashi, N. (2002) · Diabetes · doi:10.2337/diabetes.51.2007.s19 · Cited by 42
Damm, P., Handberg, A., Kuhl, C. K., Beck‐Nielsen, H., & Mølsted‐Pedersen, L. (1993) · PubMed · Cited by 42
Κousta, E., Ellard, S., Allen, L. I. S., Saker, P. J., Huxtable, S. J., Hattersley, A. T., & McCarthy, M. I. (2001) · Diabetic Medicine · doi:10.1046/j.1464-5491.2001.00530.x · Cited by 38
Damm, P., Vestergaard, H., Kühl, C., & Pedersen, O. B. (1996) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(96)70456-8 · Cited by 37
Osei, K., Gaillard, T. R., & Schuster, D. P. (1998) · Diabetes Care · doi:10.2337/diacare.21.8.1250 · Cited by 34
Garvey, W. T., Maianu, L., Zhu, J. H., et al. (1993) · Diabetes · doi:10.2337/diabetes.42.12.1773 · Cited by 33
Calpain-10 Haplotype Combination and Association With Gestational Diabetes Mellitus
Leipold, H., Knöfler, M., Gruber, C. J., Haslinger, P., Bancher‐Todesca, D., & Worda, C. (2004) · Obstetrics and Gynecology · doi:10.1097/01.aog.0000127790.15556.3d · Cited by 29 · cited 1×
“control and GDM subjects were found in genes coding for: (a) the islet-specific promoter of glucokinase (54), known to be important for glucose sensing by β cells; (b) calpain-10 (55), a gene associated with type 2 diabetes in Hispanic Americans and some other ethnic groups; (c) the sulfonylurea receptor 1 (56), which…”
BackgroundZaidi, F. K., Wareham, N. J., McCarthy, M. I., Holdstock, J., Kalloo-Hosein, H., Krook, A., Swinn, R. A., & O’ Rahilly, S. (1997) · Diabetic Medicine · doi:10.1002/(sici)1096-9136(199703)14:3<228::aid-dia330>3.0.co;2-n · Cited by 26 · cited 1×
“control and GDM subjects were found in genes coding for: (a) the islet-specific promoter of glucokinase (54), known to be important for glucose sensing by β cells; (b) calpain-10 (55), a gene associated with type 2 diabetes in Hispanic Americans and some other ethnic groups; (c) the sulfonylurea receptor 1 (56), which…”
BackgroundHELLMUTH, E., DAMM, P., MØLSTED‐PEDERSEN, L., & BENDTSON, I. (2000) · Acta Obstetricia et Gynecologica Scandinavica · doi:10.1034/j.1600-0412.2000.079011958.x · Cited by 24
Kjos, S. L., Peters, R. K., Xiang, A. H., Schaefer, U. M., & Buchanan, T. A. (1998) · PubMed · Cited by 5
Self-citation
Research works printed but not linked: 11
- Duncan, 1882, Trans. Obstet. Soc. Lond., 24, 256
- O’Sullivan, 1964, Diabetes., 13, 278
- 10.1001/jama.269.5.609 · doi:10.1001/jama.269.5.609 · Paper page
- Pettitt, 1998, Diabetes Care., 21(Suppl. 2), B138
- Silverman, 1998, Diabetes Care., 21(Suppl. 2), B142
- Catalano, 1993, Am. J. Physiol., 264, E60
- Mauricio, 1992, Diabetes Nutr. Metab., 5, 237
- Damm, 1993, Obstet. Gynecol., 82, 251
- Catalano, 2002, Am. J. Physiol., 282, E522
- Buchanan, 2003, Diabetes., 52(Suppl. 1), A34
- Kjos, 1998, Diabetes Care., 21(Suppl. 2), B50
Cited by
Lack of Exercise Is a Major Cause of Chronic Diseases
Booth, F. W., Roberts, C. K., & Laye, M. J. (2012) · Comprehensive Physiology · doi:10.1002/cphy.c110025 · Cited by 2,575
The Pathophysiology of Gestational Diabetes Mellitus
Plows, J. F., Stanley, J. L., Baker, P. N., Reynolds, C. M., & Vickers, M. H. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19113342 · Cited by 1,874
“While there is evidence that GDM can occur in all three settings [20,21], the vast majority (~80%) of GDM cases present as β-cell dysfunction on a background of chronic insulin resistance, to which the normal insulin resistance of pregnancy is partially additive [22].”
BackgroundACOG Practice Bulletin No. 190: Gestational Diabetes Mellitus
(2018) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000002501 · Cited by 1,820
Prevalence of Gestational Diabetes and Risk of Progression to Type 2 Diabetes: a Global Perspective
Zhu, Y., & Zhang, C. (2016) · Current Diabetes Reports · doi:10.1007/s11892-015-0699-x · Cited by 1,260
Role of Catalase in Oxidative Stress- and Age-Associated Degenerative Diseases
Nandi, A., Yan, L.-J., Jana, C. K., & Das, N. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/9613090 · Cited by 1,185
Metadata
- Authors
- Buchanan, T. A., & Xiang, A. H.
- Affiliations
- University of Southern California (US)
- Corresponding author
- Buchanan, Thomas A.
- Venue
- Journal of Clinical Investigation
- Published
- 2005-03-01
- Volume
- 115
- Issue
- 3
- Pages
- 485-491
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC1052018
- OpenAlex
- W2146712490
- Cited by
- 2,123
- References
- 79
- Citations by year
- 2026: 53 · 2025: 40 · 2024: 45 · 2023: 53 · 2022: 62 · 2021: 101 · 2020: 122 · 2019: 126 · 2018: 115 · 2017: 117 · 2016: 137 · 2015: 155 · 2014: 158 · 2013: 145 · 2012: 109
- FWCI
- 108.48
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed (publishedVersion)
- Funders
- American Diabetes Association
- National Institutes of Health
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK046374, R01DK61628, R01DK061628, R01DK46374)
- National Center for Research Resources (M01 RR-00043, M01RR000043)
- Topics
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- gestational diabetes mellitus, impaired glucose tolerance, pregnancy, glucose tolerance test, diabetes screening, risk factors, diabetes pathogenesis, type 2 diabetes prevention, genetic susceptibility
- MeSH terms
- Blood Glucose, Female, Humans, Insulin, Insulin Resistance, Islets of Langerhans, Mass Screening, Pregnancy, Risk Factors, Diabetes, Gestational
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.